BrainCo Completes Corporate Restructuring, Registered Capital Rises to 750M Yuan

The shift to a joint-stock company structure is the detail that matters most here: it is the standard onshore stepping stone toward a public listing, and the capital increase gives BrainCo a balance sheet more suited to a listing track than a pure R&D outfit. For China's BCI sector, a leading unicorn formalizing its corporate shell signals that the sector's most visible player is preparing for capital-market scrutiny, not just lab milestones. Whether the restructuring is followed by concrete listing steps is the open question worth watching.